Stranger than fiction.

Cramer’s five bull markets returned for a day, but he doesn’t know how long they will last.

Buy the health stock on this dip, Cramer says.

The crew debates the investor’s bond insurer bailout offer.

Applied Materials climbs on better-than-expected earnings.

Revenue falls 8%.

The data comes just ahead of a key FDA ruling on the drug.

Shares plummet again after the company’s conference call fails to address reimbursement issues.

Declines in Apple and RIM pressure the tech sector. Ambac and MBIA close lower.

Positive study results lift Valeant and Depomed.

Shares rise rise 7.2% after earnings beat estimates.